How to Navigate Ecosystem Connect NEW Distinguished Investigators 
Global Conferences RLT Education RLT Components Sponsors Trial Stats
Global Conferences RLT Education RLT Components Sponsors Trial Stats 
How to NavigateNEW Ecosystem Connect Distinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats Dictionary About Us Our Values
Contact XCancer
Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comA Phase II, Single-center, Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment
Description:
Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 treatment
Sponsor:
Fudan University
Phase:
N/A
Contacts:
Xichun Hu, MD, PhD (Principal Investigator)syner2000@163.com
64175590 ext 5006
Jian Zhang, M.D.syner2000@163.com
64175590 ext 85000
Government Study Link:
NCT04769050 - Click here to see study onClinicalTrials.gov
Share your feedback
Help us improve your experience